Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Tianjin TEDA Biomedical Engineering Company Limited per 2025 Jun 30 adalah 400.32 MM.
- Nilai operating income untuk Tianjin TEDA Biomedical Engineering Company Limited per 2025 Jun 30 adalah -31.58 MM.
- Nilai net income untuk Tianjin TEDA Biomedical Engineering Company Limited per 2025 Jun 30 adalah -30.11 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 400.32 | -31.58 | -30.11 |
2025-03-31 | 392.90 | -29.98 | -28.95 |
2024-12-31 | 385.48 | -28.38 | -27.80 |
2024-06-30 | 423.65 | -10.63 | -13.03 |
2024-03-31 | 417.36 | -14.24 | -16.34 |
2023-12-31 | 398.00 | -19.34 | -20.16 |
2023-09-30 | 449.94 | -23.46 | -23.77 |
2023-06-30 | 384.43 | -26.63 | -25.45 |
2023-03-31 | 446.90 | -28.57 | -27.94 |
2022-12-31 | 403.73 | -24.41 | -27.45 |
2022-09-30 | 424.22 | -41.86 | -65.71 |
2022-06-30 | 439.81 | -29.05 | -56.31 |
2022-03-31 | 441.17 | -22.22 | -48.13 |
2021-12-31 | 476.38 | -18.39 | -42.26 |
2021-09-30 | 474.89 | -9.54 | -30.26 |
2021-06-30 | 445.87 | -16.39 | -41.92 |
2021-03-31 | 425.24 | -21.69 | -42.57 |
2020-12-31 | 369.36 | -25.57 | -48.00 |
2020-09-30 | 325.88 | -40.21 | -86.37 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-06-30 | -0.01 | -0.01 |
2024-03-31 | -0.01 | -0.01 |
2023-12-31 | -0.01 | |
2023-09-30 | -0.01 | -0.01 |
2023-06-30 | -0.01 | -0.01 |
2023-03-31 | -0.01 | -0.01 |
2022-12-31 | -0.01 | |
2022-09-30 | -0.03 | -0.03 |
2022-06-30 | -0.03 | -0.03 |
2022-03-31 | -0.03 | -0.03 |
2021-12-31 | -0.02 | |
2021-09-30 | -0.02 | -0.02 |
2021-06-30 | -0.02 | -0.02 |
2021-03-31 | -0.02 | -0.02 |
2020-12-31 | -0.03 | |
2020-09-30 | -0.05 | -0.05 |
2020-06-30 | -0.04 | -0.04 |
2020-03-31 | -0.05 | -0.05 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Tianjin TEDA Biomedical Engineering Company Limited per 2025 Jun 30 adalah -132.71 MM.
- Nilai cash from investing activities untuk Tianjin TEDA Biomedical Engineering Company Limited per 2025 Jun 30 adalah -29.78 MM.
- Nilai kas dari aktivitas pendanaan untuk Tianjin TEDA Biomedical Engineering Company Limited per 2025 Jun 30 adalah 156.53 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -132.71 | -29.78 | 156.53 |
2025-03-31 | -79.49 | -33.51 | 119.74 |
2024-12-31 | -26.27 | -37.24 | 82.95 |
2024-06-30 | -7.03 | 0.07 | 17.70 |
2024-03-31 | |||
2023-12-31 | -13.15 | -0.47 | 12.73 |
2023-09-30 | |||
2023-06-30 | 10.73 | -11.02 | 2.57 |
2023-03-31 | |||
2022-12-31 | -12.82 | -12.93 | 6.17 |
2022-09-30 | |||
2022-06-30 | -46.29 | -10.50 | 35.20 |
2022-03-31 | |||
2021-12-31 | -6.68 | -8.51 | 28.10 |
2021-09-30 | |||
2021-06-30 | 63.99 | -27.51 | -21.49 |
2021-03-31 | |||
2020-12-31 | 35.99 | -26.51 | -20.19 |
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | 0.00 | -0.02 |
2024-12-31 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Efektivitas Manajemen
- roa untuk Tianjin TEDA Biomedical Engineering Company Limited pada 2025 Jun 30 adalah -0.09.
- roe untuk Tianjin TEDA Biomedical Engineering Company Limited pada 2025 Jun 30 adalah -0.47.
- roic untuk Tianjin TEDA Biomedical Engineering Company Limited pada 2025 Jun 30 adalah -0.15.
- croic untuk Tianjin TEDA Biomedical Engineering Company Limited pada 2025 Jun 30 adalah 0.10.
- ocroic untuk Tianjin TEDA Biomedical Engineering Company Limited pada 2025 Jun 30 adalah -0.14.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.09 | -0.47 | -0.15 | 0.10 | -0.14 |
2025-03-31 | 0.00 | ||||
2024-12-31 | -0.04 | -0.43 | -0.08 | 0.06 | -0.04 |
2024-06-30 | -0.06 | -0.20 | -0.14 | -0.01 | -0.09 |
2024-03-31 | -0.24 | -0.14 | -0.01 | -0.09 | |
2023-12-31 | -0.05 | -0.24 | -0.14 | 0.01 | 0.06 |
2023-09-30 | -0.05 | -0.27 | -0.16 | 0.01 | 0.06 |
2023-06-30 | -0.06 | -0.27 | -0.16 | 0.01 | 0.06 |
2023-03-31 | -0.25 | -0.16 | 0.00 | 0.00 | |
2022-12-31 | -0.15 | -0.42 | -0.34 | 0.00 | 0.00 |
2022-09-30 | -0.13 | -0.42 | -0.34 | -0.11 | -0.24 |
2022-06-30 | -0.11 | -0.36 | -0.30 | -0.12 | -0.25 |
2022-03-31 | -0.08 | -0.31 | -0.44 | 0.00 | 0.00 |
2021-12-31 | -0.08 | -0.27 | -0.24 | 0.07 | 0.00 |
2021-09-30 | -0.08 | -0.12 | -0.14 | 0.07 | 0.30 |
2021-06-30 | -0.11 | -0.16 | -0.21 | 0.08 | 0.33 |
2021-03-31 | -0.12 | -0.21 | -0.20 | -0.05 | 0.17 |
2020-12-31 | -0.13 | -0.23 | -0.23 | -0.05 | 0.17 |
2020-09-30 | -0.19 | -0.30 | -0.31 | -0.01 | 0.04 |
2020-06-30 | -0.18 | -0.29 | -0.29 | -0.01 | 0.04 |
2020-03-31 | -0.19 | -0.30 | -0.36 | -0.08 | -0.02 |
Gross Margins
- marjin kotor untuk Tianjin TEDA Biomedical Engineering Company Limited pada 2025 Jun 30 adalah 0.04.
- marjin bersih untuk Tianjin TEDA Biomedical Engineering Company Limited pada 2025 Jun 30 adalah -0.07.
- marjin operasi untuk Tianjin TEDA Biomedical Engineering Company Limited pada 2025 Jun 30 adalah -0.07.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.04 | -0.07 | -0.07 |
2025-03-31 | |||
2024-12-31 | 0.06 | -0.03 | -0.03 |
2024-06-30 | 0.05 | -0.05 | -0.05 |
2024-03-31 | 0.05 | -0.05 | -0.05 |
2023-12-31 | 0.04 | -0.05 | -0.05 |
2023-09-30 | 0.03 | -0.06 | -0.07 |
2023-06-30 | 0.03 | -0.06 | -0.07 |
2023-03-31 | 0.04 | -0.06 | -0.06 |
2022-12-31 | 0.04 | -0.15 | -0.10 |
2022-09-30 | 0.06 | -0.15 | -0.10 |
2022-06-30 | 0.08 | -0.13 | -0.07 |
2022-03-31 | 0.12 | -0.11 | -0.05 |
2021-12-31 | 0.12 | -0.09 | -0.04 |
2021-09-30 | 0.12 | -0.06 | -0.02 |
2021-06-30 | 0.12 | -0.09 | -0.04 |
2021-03-31 | 0.12 | -0.10 | -0.05 |
2020-12-31 | 0.11 | -0.13 | -0.07 |
2020-09-30 | 0.08 | -0.27 | -0.12 |
2020-06-30 | 0.07 | -0.26 | -0.13 |
2020-03-31 | 0.08 | -0.26 | -0.12 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |